XCNQBBM
Market cap4mUSD
Dec 20, Last price
0.02CAD
1D
0.00%
1Q
-25.00%
IPO
-98.75%
Name
Blueberries Medical Corp
Chart & Performance
Profile
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. The company is headquartered in Bogotá, Colombia.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 288 22.44% | 235 69.70% | 139 110.29% | |||||||
Cost of revenue | 1,441 | 1,482 | 964 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (1,152) | (1,247) | (825) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (550) | 174 | ||||||||
Tax Rate | ||||||||||
NOPAT | (1,152) | (697) | (999) | |||||||
Net income | (1,635) 78.23% | (918) -82.76% | (5,321) 6.84% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 1,981 | 1,467 | 2,838 | |||||||
BB yield | -45.17% | -43.43% | -27.30% | |||||||
Debt | ||||||||||
Debt current | 2 | 1,197 | 1,216 | |||||||
Long-term debt | 24 | 329 | 555 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | (793) | 114 | 428 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (1,333) | (1,469) | (1,680) | |||||||
CAPEX | (22) | (49) | ||||||||
Cash from investing activities | 383 | 102 | (49) | |||||||
Cash from financing activities | 539 | 1,346 | 2,766 | |||||||
FCF | (901) | (58) | 945 | |||||||
Balance | ||||||||||
Cash | 818 | 1,413 | 1,343 | |||||||
Long term investments | ||||||||||
Excess cash | 804 | 1,401 | 1,336 | |||||||
Stockholders' equity | (5,001) | (5,368) | (5,268) | |||||||
Invested Capital | 6,960 | 8,172 | 8,141 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 219,299 | 168,887 | 148,505 | |||||||
Price | 0.02 0.00% | 0.02 -71.43% | 0.07 -30.00% | |||||||
Market cap | 4,386 29.85% | 3,378 -67.51% | 10,395 -16.12% | |||||||
EV | 3,593 | 3,491 | 10,823 | |||||||
EBITDA | (1,003) | (951) | 4 | |||||||
EV/EBITDA | 3,030.85 | |||||||||
Interest | 264 | 360 | 269 | |||||||
Interest/NOPBT |